Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Nausea, Vomiting
In brief
SPECIFIC AIMS * Assess risk factors for nausea and vomiting in c-section patients undergoing regional anesthesia * Quantify the incidence of nausea and vomiting intraoperatively and postoperatively in the ginger and placebo groups. * Quantify post-operative analgesia and pruritus in the ginger and placebo groups * Quantify patient satisfaction of the ginger and placebo groups * Assess patient expectation of ginger on post-op day three
Key facts
- Study ID
- NCT01733212
- Run by
- Joel Yarmush
- People needed
- 239
- Starts
- 2010-06-01
- Expected to finish
- 2011-07-01
- Last updated by the study team
- 2021-09-10
Who can join
Age: 20 and older, up to 49. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Healthy (i.e., ASA I, or II) patients presenting for planned c-section at New York Methodist Hospital
- Signed informed consent
You may not qualify if…
- They are unable or unwilling to take part in the study
- They have a history of an allergy to any medications used including ginger
- They have had any gastrointestinal surgery on the stomach, small intestine, or gall bladder.
- They have any history of bleeding disorder, (i.e., Hemophilia A/B, ITP, etc.)
- They have a contraindication to intrathecal or epidural anesthesia. ( i.e., Arnold- Chiari malformation, etc.)
- They are unable to understand instructions or questions related to study
- ASA III or IV patients
Where it is running
- New York Methodist Hospital — Brooklyn, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.